InsidersTradesSigma
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the complete record of transactions filed by Colwill Bruce, 首席财务官. Insider active across 1 company, notably InMed Pharmaceuticals Inc.. Cumulatively, 2 filings have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €12k. History available since 28 September 2021. The latest transaction was disclosed on 24 January 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Bruce Colwill is the Chief Financial Officer of InMed Pharmaceuticals Inc. He is responsible for the financial management of the company, including budgeting, financial risk management, and regulatory compliance. Bruce plays a crucial role in the strategic direction of InMed, which focuses on developing cannabis-based therapies. His expertise in corporate finance is essential to support growth and innovation within the company.